Can I Take 5-HTP with Belsomra (Suvorexant)?
A clinical review of the 5-HTP and suvorexant (Belsomra) interaction: mechanism, serotonin syndrome risk, safe-use guidance, and what to tell your prescriber.
Read clinical reviewTopic Hub
30 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 30 of 30 clinical reviews.
A clinical review of the 5-HTP and suvorexant (Belsomra) interaction: mechanism, serotonin syndrome risk, safe-use guidance, and what to tell your prescriber.
Read clinical reviewEvidence-based guide on combining alpha-lipoic acid with Belsomra (suvorexant). Covers interaction mechanisms, blood sugar monitoring, thyroid effects, dose-separation strategies, and clinical safety data.
Read clinical reviewA clinical review of the pharmacokinetic and pharmacodynamic interactions between ashwagandha (KSM-66, Sensoril) and suvorexant (Belsomra), with dosing guidance, monitoring parameters, and safety recommendations.
Read clinical reviewA clinician-reviewed guide to the berberine-suvorexant interaction: pharmacokinetics, CYP3A4 inhibition, sedation risk, dosing strategies, and monitoring guidance.
Read clinical reviewLearn whether caffeine interacts with Belsomra (suvorexant), how the two compounds oppose each other pharmacodynamically, what doses and timing matter, and when to call your prescriber.
Read clinical reviewA clinician-reviewed guide to taking calcium supplements with Belsomra (suvorexant). Learn whether any interaction exists, what the evidence shows, and how to time your doses safely.
Read clinical reviewEvidence-based guide on combining CoQ10 supplements with Belsomra (suvorexant) for insomnia. Covers drug interactions, CYP3A4 metabolism, dose timing, monitoring, and safety data.
Read clinical reviewA clinician-reviewed guide to taking creatine with Belsomra (suvorexant): pharmacokinetic interaction risk, creatinine elevation, renal monitoring, and practical dosing guidance.
Read clinical reviewA clinician-reviewed guide to the folate, suvorexant interaction: pharmacokinetics, MTHFR considerations, dosing windows, monitoring, and safety guidance for adults taking Belsomra for insomnia.
Read clinical reviewA physician-reviewed guide to the ginseng, suvorexant interaction: pharmacokinetics, CYP3A4 competition, CNS sedation overlap, blood-sugar effects, and step-by-step monitoring for anyone taking both.
Read clinical reviewA board-reviewed clinical guide to the pharmacokinetic and pharmacodynamic interaction between glutathione supplements and suvorexant (Belsomra), with dosing context, monitoring guidance, and safety considerations.
Read clinical reviewA physician-reviewed guide to combining glycine supplements with Belsomra (suvorexant), covering interaction mechanisms, safety evidence, dosing, and monitoring guidance.
Read clinical reviewA clinical breakdown of the pharmacokinetic and pharmacodynamic interactions between green tea extract / EGCG and suvorexant (Belsomra), including dose guidance, hepatotoxicity risk, and monitoring recommendations from the HealthRX medical team.
Read clinical reviewA clinician-reviewed guide to combining L-theanine and Belsomra (suvorexant): mechanism, interaction type, safety evidence, dose timing, and when to call your prescriber.
Read clinical reviewA physician-reviewed guide to the lion's mane and Belsomra (suvorexant) interaction: mechanisms, risks, dosing timing, and monitoring recommendations.
Read clinical reviewA clinical review of the magnesium-suvorexant interaction: pharmacokinetics, pharmacodynamics, safety data, dosing guidance, and monitoring recommendations for patients combining these two sleep aids.
Read clinical reviewA clinical review of the melatonin and Belsomra (suvorexant) interaction: mechanism, safety, dosing, and what your prescriber needs to know before you combine them.
Read clinical reviewA clinician-reviewed guide to taking NAC with suvorexant (Belsomra), covering pharmacokinetic and pharmacodynamic interaction risks, dosing windows, monitoring, and safety recommendations.
Read clinical reviewEvidence-based review of taking omega-3 fish oil supplements with suvorexant (Belsomra) for insomnia, covering drug-supplement interactions, antiplatelet concerns, CYP3A4 metabolism, and clinical monitoring.
Read clinical reviewA clinical review of the quercetin-suvorexant interaction, covering CYP3A4 pharmacokinetics, sedation risks, dose timing, and monitoring guidance for patients on Belsomra.
Read clinical reviewA physician-reviewed guide to the pharmacokinetic and pharmacodynamic interactions between reishi mushroom and suvorexant (Belsomra), with dosing context, monitoring advice, and practical clinical guidance.
Read clinical reviewA clinical review of the resveratrol, suvorexant interaction: CYP3A4 inhibition, pharmacokinetic risks, dosing guidance, and monitoring recommendations for patients taking Belsomra.
Read clinical reviewA clinician-reviewed guide to the pharmacokinetic and pharmacodynamic interactions between rhodiola rosea and suvorexant (Belsomra), including safety signals, dose timing, and monitoring steps.
Read clinical reviewA clinician-reviewed guide to taking saw palmetto with Belsomra (suvorexant), covering pharmacokinetic interactions, CYP3A4 metabolism, mild anticoagulant concerns, and practical monitoring steps.
Read clinical reviewSt. John's Wort is a potent CYP3A4 inducer that significantly reduces suvorexant blood levels, making Belsomra less effective for insomnia. Learn the mechanism, the clinical risk, and what to do if you are already taking both.
Read clinical reviewA detailed clinical review of the pharmacokinetic and pharmacodynamic interaction between turmeric / curcumin supplements and suvorexant (Belsomra), with dosing guidance, monitoring tips, and safety thresholds.
Read clinical reviewA physician-reviewed guide covering the pharmacokinetic and pharmacodynamic interaction profile between suvorexant (Belsomra) and vitamin B12, including dosing timing, monitoring, and safety guidance.
Read clinical reviewA clinician-reviewed guide to taking vitamin B6 with Belsomra (suvorexant): pharmacokinetic and pharmacodynamic interaction data, safe dose ranges, monitoring guidance, and when to call your prescriber.
Read clinical reviewA board-reviewed guide to taking vitamin D with Belsomra (suvorexant): pharmacokinetic interaction risk, CYP3A4 considerations, dosing guidance, and monitoring recommendations.
Read clinical reviewA physician-reviewed guide to combining zinc supplements with Belsomra (suvorexant), covering pharmacokinetic interactions, CYP3A4 considerations, copper balance, and safe dosing practices.
Read clinical review